磺胺嘧啶银气雾剂对铜绿假单胞菌及金黄色葡萄球菌生物膜的体外评价
本研究体外测试含磺胺嘧啶银、维生素A和利多卡因的气雾剂配方(AF-SSD)对铜绿假单胞菌及MRSA、MSSA生物膜的抗菌活性。通过代谢活性、生物膜生物量、CFU计数及活死染色评估,AF-SSD明显影响三种菌株生物膜的活性、生物量和结构,对铜绿假单胞菌生物膜在400倍稀释下、对MRSA和MSSA分别在100倍和10倍稀释下显示完全杀菌活性。气雾给药避免直接接触创面并减少重复使用污染,支持该配方作为传统磺胺嘧啶银治疗的潜在改进。
要点
- AF-SSD气雾剂对铜绿假单胞菌、MRSA和MSSA生物膜均有明显抗生物膜作用。
- 对铜绿假单胞菌生物膜400倍稀释即达完全杀菌,MRSA需100倍,MSSA需10倍。
- 气雾给药无需直接接触创面,可避免产品重复使用后的污染。
核心结论
- AF-SSD气雾剂在体外对铜绿假单胞菌及MRSA、MSSA生物膜显示强抗生物膜和杀菌活性。
- 结果支持该气雾剂配方作为传统磺胺嘧啶银治疗潜在改进的进一步研究。
研究设计与样本
- 体外研究,测试AF-SSD(磺胺嘧啶银、维生素A和利多卡因气雾剂配方)对铜绿假单胞菌及MRSA、MSSA菌株生物膜的活性。
主要发现
- AF-SSD明显影响三种测试菌株生物膜的活性、生物量和结构。
- AF-SSD对铜绿假单胞菌生物膜在400倍稀释时显示完全杀菌活性。
- AF-SSD对MRSA和MSSA生物膜分别在100倍和10倍稀释时显示完全杀菌活性。
关键数值与推荐
- 采用resazurin法测代谢活性/活力,结晶紫染色测生物膜生物量,CFU计数及共聚焦显微镜活死染色分析。
临床怎么用
- 气雾给药可在不直接接触创面的情况下施用AF-SSD,并避免重复使用导致的产品污染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The risk of infection of skin and soft tissue chronic wounds by gram-negative and gram-positive pathogens growing in biofilms is a major health-care concern. In this study we test a formulation of silver sulfadiazine, vitamin A and lidocaine (AF-SSD) for aerosol administration against biofilms of Pseudomonas aeruginosa and biofilms of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) strains of Staphylococcus aureus. The aerosol allows the administration of AF-SSD without the direct contact with the wound and avoids contamination of the product after reiterative usage. We evaluated in vitro the anti-biofilm activity of AF-SSD by carrying out different technical approaches such as resazurin assays to measure metabolic activity/viability, crystal violet staining assays to determine biofilm biomass, counting of CFUs and live/dead staining for confocal microscopy analysis. AF-SSD clearly affected biofilm viability, biomass and structure, in the three bacterial strains tested. AF-SSD displayed a strong anti-biofilm effect, showing total bactericidal activity on biofilms of P. aeruginosa at a 400-fold dilution of the product, and after a 100-fold and 10-fold dilution for MRSA and MSSA, respectively. Considering the benefits of aerosol administration, our results support this kind of formulation as a potential improvement over conventional treatments with silver sulfadiazine.
引用
- Moyano AJ, Mas CR, Colque CA, et al. Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine. Burns. 2019. PMID: 31420266. doi:10.1016/j.burns.2019.07.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。